Chelator efficacy of deferasirox and deferoxamine determined by SQUID biosusceptometry.

被引:0
|
作者
Grosse, Regine
Janssen, Gisela
Engelhardt, Rainer
Groeger, Marketa
Leismann, Oliver
Nielsen, Peter
Fischer, Roland
Janka, Gritta
机构
[1] Univ Hamburg, Med Ctr, Interdisciplinary Clin Grp Metabolism, Hamburg, Germany
[2] Univ Dusseldorf, D-4000 Dusseldorf, Germany
[3] Novartis Pharma GmbH, Nurnberg, Germany
[4] Childrens Hosp & Res Ctr, HEDCO, Oakland, CA USA
关键词
D O I
10.1182/blood.V108.11.1779.1779
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1779
引用
收藏
页码:505A / 505A
页数:1
相关论文
共 24 条
  • [21] Compare the Efficacy and Safety of Deferoxamine, Deferasirox, and Deferiprone in Patients With Sickle Cell Disease or Transfusion-Dependent Anemia: A Network Meta-Analysis of Randomized Control Trials
    Agbor, Divine Besong Arrey
    Karumanchi, Abhimanyu
    Adivi, Santoshini
    Mohammed, Mohammed A.
    Ur Rehman, Wajeeh
    Chaudhari, Sandipkumar S.
    Soe, Thin M.
    Ali, Neelum
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [22] Long-term efficacy and safety of deferasirox (Exjade®, ICL670), a once-daily oral iron chelator, in patients with sickle cell disease (SCD)
    Vichinsky, Elliott
    Coates, Thomas D.
    Thompson, Alexis A.
    Mueller, Brigitta U.
    Lagrone, Darlene
    Heeney, Matthew M.
    BLOOD, 2007, 110 (11) : 995A - 995A
  • [23] Deferasirox (Exjade®), the Once-Daily Oral Iron Chelator, Demonstrates Safety and Efficacy in Patients with Sickle Cell Disease (SCD): 3.5-Year Follow-up.
    Vichinsky, Elliott
    Coates, Thomas
    Thompson, Alexis A.
    Bernaudin, Francoise
    Rodriguez, Martha
    Rojkjaer, Lisa
    Heeney, Matthew M.
    BLOOD, 2008, 112 (11) : 506 - 506
  • [24] Ethical Issues and Risk/Benefit Assessment of Iron Chelation Therapy: Advances with Deferiprone/deferoxamine Combinations and Concerns about the Safety, Efficacy and Costs of Deferasirox [Kontoghiorghes GJ, Hemoglobin 2008; 32(1-2):1-15.]
    Porter, John B.
    Taher, Ali T.
    Cappellini, Maria D.
    Vichinsky, Elliott P.
    HEMOGLOBIN, 2008, 32 (06) : 601 - 607